GTCR Promotes John Kos and Jeff Heh to Principal

October 30, 2017

CHICAGO, IL – September 27, 2017 

GTCR, a leading Chicago-based private equity firm, recently named John Kos and Jeff Heh as Principals of the firm.

Mr. Kos joined GTCR in 2006 as an Associate and became a Vice President in the firm’s Healthcare Group in 2011. Mr. Kos has been an active leader in a number of important healthcare investments including Cole-Parmer, RX30, Xifin, Riverchase Dermatology, Cedar Gate Technologies and GreatCall. Prior to joining GTCR, Mr. Kos worked an Analyst in the Healthcare Group of Citigroup Global Markets in New York. He holds an MBA with distinction from Harvard Business School and a BS in finance with highest honors from the University of Illinois.

Mr. Heh joined the Capital Markets Group at GTCR as a Vice President in 2013, where he focuses on the firm’s debt financing activities for both new and existing investments. Mr. Heh has been instrumental in the financing of several recent investments, including Albany Molecular, GreatCall, RevSpring and TerSera, as well as numerous other portfolio company financings. Prior to joining GTCR, Mr. Heh worked as a Vice President in the Leveraged Finance Group at J.P. Morgan. He holds a BS from the University of Richmond with a concentration in finance.

Said Craig Bondy, Managing Director at GTCR, “We are excited to see the continued growth of our senior investment professional team as exemplified by the well-deserved promotions of John and Jeff.  Overall, we have a very strong professional team at GTCR that is getting deeper and more experienced.”

About GTCR

Founded in 1980, GTCR is a leading private equity firm focused on investing in growth companies in the Financial Services & Technology, Healthcare, Technology, Media & Telecommunications and Growth Business Services industries. The Chicago-based firm pioneered The Leaders Strategy™ – finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through transformational acquisitions and organic growth. Since its inception, GTCR has invested more than $14 billion in over 200 companies. For more information, please visit www.gtcr.com.

Media inquiries
Eileen Rochford
+1 (312) 953-3305
eileenr@theharbingergroup.com